1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Contract Research Organizations (CROs)
1.2.3 Business Process Outsourcing (BPOs)
1.3 Market by Application
1.3.1 Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Premarketing Clinical Trial
1.3.3 Post-marketing Clinical Practice
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global Pharmacovigilance (PV) Outsourcing Market Perspective (2017-2028)
2.2 Pharmacovigilance (PV) Outsourcing Growth Trends by Region
2.2.1 Pharmacovigilance (PV) Outsourcing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Pharmacovigilance (PV) Outsourcing Historic Market Size by Region (2017-2022)
2.2.3 Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Region (2023-2028)
2.3 Pharmacovigilance (PV) Outsourcing Market Dynamics
2.3.1 Pharmacovigilance (PV) Outsourcing Industry Trends
2.3.2 Pharmacovigilance (PV) Outsourcing Market Drivers
2.3.3 Pharmacovigilance (PV) Outsourcing Market Challenges
2.3.4 Pharmacovigilance (PV) Outsourcing Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Pharmacovigilance (PV) Outsourcing Players by Revenue
3.1.1 Global Top Pharmacovigilance (PV) Outsourcing Players by Revenue (2017-2022)
3.1.2 Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Players (2017-2022)
3.2 Global Pharmacovigilance (PV) Outsourcing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmacovigilance (PV) Outsourcing Revenue
3.4 Global Pharmacovigilance (PV) Outsourcing Market Concentration Ratio
3.4.1 Global Pharmacovigilance (PV) Outsourcing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacovigilance (PV) Outsourcing Revenue in 2021
3.5 Pharmacovigilance (PV) Outsourcing Key Players Head office and Area Served
3.6 Key Players Pharmacovigilance (PV) Outsourcing Product Solution and Service
3.7 Date of Enter into Pharmacovigilance (PV) Outsourcing Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Pharmacovigilance (PV) Outsourcing Breakdown Data by Type
4.1 Global Pharmacovigilance (PV) Outsourcing Historic Market Size by Type (2017-2022)
4.2 Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Type (2023-2028) 5 Pharmacovigilance (PV) Outsourcing Breakdown Data by Application
5.1 Global Pharmacovigilance (PV) Outsourcing Historic Market Size by Application (2017-2022)
5.2 Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Application (2023-2028) 6 North America
6.1 North America Pharmacovigilance (PV) Outsourcing Market Size (2017-2028)
6.2 North America Pharmacovigilance (PV) Outsourcing Market Size by Type
6.2.1 North America Pharmacovigilance (PV) Outsourcing Market Size by Type (2017-2022)
6.2.2 North America Pharmacovigilance (PV) Outsourcing Market Size by Type (2023-2028)
6.2.3 North America Pharmacovigilance (PV) Outsourcing Market Share by Type (2017-2028)
6.3 North America Pharmacovigilance (PV) Outsourcing Market Size by Application
6.3.1 North America Pharmacovigilance (PV) Outsourcing Market Size by Application (2017-2022)
6.3.2 North America Pharmacovigilance (PV) Outsourcing Market Size by Application (2023-2028)
6.3.3 North America Pharmacovigilance (PV) Outsourcing Market Share by Application (2017-2028)
6.4 North America Pharmacovigilance (PV) Outsourcing Market Size by Country
6.4.1 North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2017-2022)
6.4.2 North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada 7 Europe
7.1 Europe Pharmacovigilance (PV) Outsourcing Market Size (2017-2028)
7.2 Europe Pharmacovigilance (PV) Outsourcing Market Size by Type
7.2.1 Europe Pharmacovigilance (PV) Outsourcing Market Size by Type (2017-2022)
7.2.2 Europe Pharmacovigilance (PV) Outsourcing Market Size by Type (2023-2028)
7.2.3 Europe Pharmacovigilance (PV) Outsourcing Market Share by Type (2017-2028)
7.3 Europe Pharmacovigilance (PV) Outsourcing Market Size by Application
7.3.1 Europe Pharmacovigilance (PV) Outsourcing Market Size by Application (2017-2022)
7.3.2 Europe Pharmacovigilance (PV) Outsourcing Market Size by Application (2023-2028)
7.3.3 Europe Pharmacovigilance (PV) Outsourcing Market Share by Application (2017-2028)
7.4 Europe Pharmacovigilance (PV) Outsourcing Market Size by Country
7.4.1 Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2017-2022)
7.4.2 Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size (2017-2028)
8.2 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Type
8.2.1 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Share by Type (2017-2028)
8.3 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Application
8.3.1 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Share by Application (2017-2028)
8.4 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Region
8.4.1 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia 9 Latin America
9.1 Latin America Pharmacovigilance (PV) Outsourcing Market Size (2017-2028)
9.2 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Type
9.2.1 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Type (2017-2022)
9.2.2 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Type (2023-2028)
9.2.3 Latin America Pharmacovigilance (PV) Outsourcing Market Share by Type (2017-2028)
9.3 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Application
9.3.1 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Application (2017-2022)
9.3.2 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Application (2023-2028)
9.3.3 Latin America Pharmacovigilance (PV) Outsourcing Market Share by Application (2017-2028)
9.4 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country
9.4.1 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country (2017-2022)
9.4.2 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size (2017-2028)
10.2 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Type
10.2.1 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Share by Type (2017-2028)
10.3 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Application
10.3.1 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Share by Application (2017-2028)
10.4 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country
10.4.1 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE 11 Key Players Profiles
11.1 Accenture
11.1.1 Accenture Company Details
11.1.2 Accenture Business Overview
11.1.3 Accenture Pharmacovigilance (PV) Outsourcing Introduction
11.1.4 Accenture Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.1.5 Accenture Recent Developments
11.2 C3i Solutions
11.2.1 C3i Solutions Company Details
11.2.2 C3i Solutions Business Overview
11.2.3 C3i Solutions Pharmacovigilance (PV) Outsourcing Introduction
11.2.4 C3i Solutions Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.2.5 C3i Solutions Recent Developments
11.3 Clintec
11.3.1 Clintec Company Details
11.3.2 Clintec Business Overview
11.3.3 Clintec Pharmacovigilance (PV) Outsourcing Introduction
11.3.4 Clintec Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.3.5 Clintec Recent Developments
11.4 Covance
11.4.1 Covance Company Details
11.4.2 Covance Business Overview
11.4.3 Covance Pharmacovigilance (PV) Outsourcing Introduction
11.4.4 Covance Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.4.5 Covance Recent Developments
11.5 Deloitte Touche Tohmatsu Limited
11.5.1 Deloitte Touche Tohmatsu Limited Company Details
11.5.2 Deloitte Touche Tohmatsu Limited Business Overview
11.5.3 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Introduction
11.5.4 Deloitte Touche Tohmatsu Limited Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.5.5 Deloitte Touche Tohmatsu Limited Recent Developments
11.6 ELC Group
11.6.1 ELC Group Company Details
11.6.2 ELC Group Business Overview
11.6.3 ELC Group Pharmacovigilance (PV) Outsourcing Introduction
11.6.4 ELC Group Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.6.5 ELC Group Recent Developments
11.7 Ergomed
11.7.1 Ergomed Company Details
11.7.2 Ergomed Business Overview
11.7.3 Ergomed Pharmacovigilance (PV) Outsourcing Introduction
11.7.4 Ergomed Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.7.5 Ergomed Recent Developments
11.8 iGATE Corporation
11.8.1 iGATE Corporation Company Details
11.8.2 iGATE Corporation Business Overview
11.8.3 iGATE Corporation Pharmacovigilance (PV) Outsourcing Introduction
11.8.4 iGATE Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.8.5 iGATE Corporation Recent Developments
11.9 iMED Global Corporation
11.9.1 iMED Global Corporation Company Details
11.9.2 iMED Global Corporation Business Overview
11.9.3 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Introduction
11.9.4 iMED Global Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.9.5 iMED Global Corporation Recent Developments
11.10 IQVIA
11.10.1 IQVIA Company Details
11.10.2 IQVIA Business Overview
11.10.3 IQVIA Pharmacovigilance (PV) Outsourcing Introduction
11.10.4 IQVIA Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.10.5 IQVIA Recent Developments
11.11 MarksMan Healthcare
11.11.1 MarksMan Healthcare Company Details
11.11.2 MarksMan Healthcare Business Overview
11.11.3 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Introduction
11.11.4 MarksMan Healthcare Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.11.5 MarksMan Healthcare Recent Developments
11.12 Medpace Holdings
11.12.1 Medpace Holdings Company Details
11.12.2 Medpace Holdings Business Overview
11.12.3 Medpace Holdings Pharmacovigilance (PV) Outsourcing Introduction
11.12.4 Medpace Holdings Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.12.5 Medpace Holdings Recent Developments
11.13 Novartis
11.13.1 Novartis Company Details
11.13.2 Novartis Business Overview
11.13.3 Novartis Pharmacovigilance (PV) Outsourcing Introduction
11.13.4 Novartis Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.13.5 Novartis Recent Developments
11.14 Oracle Corporation
11.14.1 Oracle Corporation Company Details
11.14.2 Oracle Corporation Business Overview
11.14.3 Oracle Corporation Pharmacovigilance (PV) Outsourcing Introduction
11.14.4 Oracle Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.14.5 Oracle Corporation Recent Developments
11.15 Parexel
11.15.1 Parexel Company Details
11.15.2 Parexel Business Overview
11.15.3 Parexel Pharmacovigilance (PV) Outsourcing Introduction
11.15.4 Parexel Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.15.5 Parexel Recent Developments
11.16 PharmInvent
11.16.1 PharmInvent Company Details
11.16.2 PharmInvent Business Overview
11.16.3 PharmInvent Pharmacovigilance (PV) Outsourcing Introduction
11.16.4 PharmInvent Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.16.5 PharmInvent Recent Developments
11.17 PrimeVigilance
11.17.1 PrimeVigilance Company Details
11.17.2 PrimeVigilance Business Overview
11.17.3 PrimeVigilance Pharmacovigilance (PV) Outsourcing Introduction
11.17.4 PrimeVigilance Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.17.5 PrimeVigilance Recent Developments
11.18 Pure Drug Safety
11.18.1 Pure Drug Safety Company Details
11.18.2 Pure Drug Safety Business Overview
11.18.3 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Introduction
11.18.4 Pure Drug Safety Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.18.5 Pure Drug Safety Recent Developments
11.19 Sciformix
11.19.1 Sciformix Company Details
11.19.2 Sciformix Business Overview
11.19.3 Sciformix Pharmacovigilance (PV) Outsourcing Introduction
11.19.4 Sciformix Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.19.5 Sciformix Recent Developments
11.20 SIRO Clinpharm
11.20.1 SIRO Clinpharm Company Details
11.20.2 SIRO Clinpharm Business Overview
11.20.3 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Introduction
11.20.4 SIRO Clinpharm Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.20.5 SIRO Clinpharm Recent Developments
11.21 Symogen
11.21.1 Symogen Company Details
11.21.2 Symogen Business Overview
11.21.3 Symogen Pharmacovigilance (PV) Outsourcing Introduction
11.21.4 Symogen Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.21.5 Symogen Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
